Hepatitis C News and Research

Latest Hepatitis C News and Research

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Researchers at the University of Washington show that methylene blue (MB) and light can decontaminate masks and respirators by inactivating three tested coronaviruses without compromising integrity. The method is effective, low-cost, and does not require specialized equipment, making it applicable in any setting.

16 Dec 2020

Drug may increase vaccine protection in older adults

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.

15 Dec 2020

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

The light at the end of the pandemic tunnel is getting brighter. This week, the first health care workers will receive the first doses of an FDA-approved coronavirus vaccine. Soon, so will other front-line workers in health care and beyond, and residents of long-term care facilities.

15 Dec 2020

Multisystem immune-related adverse events linked with improved survival from immunotherapy in NSCLC

The results of a large, retrospective study of patients who received a form of immunotherapy for non-small cell lung cancer (NSCLC) revealed that patients may get more than one immune-related side effect, and identified a correlation between these multisystem immune-related adverse events (irAEs) and improved patient survival.

14 Dec 2020

Remdesivir likely to be highly effective treatment for COVID-19

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.

14 Dec 2020

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

In the current COVID-19 pandemic, SARS-CoV-2 has led to millions of infections worldwide, with over 1.5 million deaths.

14 Dec 2020

Beta-blockers show anti-inflammatory effects in cirrhosis

Approximately 170,000 people die every year in Europe from the direct consequences of advanced chronic liver disease (cirrhosis).

10 Dec 2020

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Researchers in the United States have conducted a study suggesting that a small proportion of people living in Seattle were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – by around late March/early April 2020.

9 Dec 2020

Depressed children, teenagers have higher risk of premature death and wide range of diseases

Depressed children and teenagers have an increased risk of suffering from premature death and a wide range of illnesses later in life.

9 Dec 2020

Amilorides reduce SARS-CoV-2 viral replication in vitro

A new U.S. study published on the bioRxiv preprint server reports the use of an amiloride-based scaffold that targets a viral RNA structure known to be essential in viral replication in the 5’-untranslated region (UTR) of the virus. The researchers say this heralds the application of these molecules as chemical probes to explore viral biology and produce specific antivirals targeting RNA regions of the coronavirus genome.

8 Dec 2020

COVID-19 pandemic has led to a decrease in hospital-wide HCV testing

New research from Boston Medical Center finds that the COVID-19 emergency systemic changes made to decrease in-person visits during the pandemic have led to a decrease in hospital-wide Hepatitis C (HCV) testing by 50 percent, and a reduction in new HCV diagnoses by more than 60 percent.

4 Dec 2020

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

A team of San Diego Supercomputer Center (SDSC) researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19.

2 Dec 2020

How COVID-19 highlights the uncertainty of medical testing

Dr. Jacqueline Chu considered the man with a negative coronavirus test on the other end of the phone, and knew, her heart dropping, that the test result was not enough to clear him for work.

1 Dec 2020

Good cholesterol helps SARS-CoV-2 enter cells

The researchers explained that the SARS-CoV-2 can infect human host cells after its viral spike protein (SARS-2-S) binds to a cellular surface receptor called the angiotensin-converting enzyme 2 (ACE2).

30 Nov 2020

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

Many countries in resource-limited settings have high HIV, malaria, tuberculosis, hepatitis, and/or sexually transmitted infection (STI) burdens.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

Hepatitis C News and Research

Latest Hepatitis C News and Research

Methylene blue and light inactivates SARS-CoV-2 on N95 respirators and masks, study finds

Drug may increase vaccine protection in older adults

Pediatricians want kids to be part of COVID vaccine trials

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

Multisystem immune-related adverse events linked with improved survival from immunotherapy in NSCLC

Remdesivir likely to be highly effective treatment for COVID-19

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

Beta-blockers show anti-inflammatory effects in cirrhosis

Study suggests vast majority of Seattle population remains susceptible to COVID-19

Depressed children, teenagers have higher risk of premature death and wide range of diseases

Amilorides reduce SARS-CoV-2 viral replication in vitro

COVID-19 pandemic has led to a decrease in hospital-wide HCV testing

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

How COVID-19 highlights the uncertainty of medical testing

Good cholesterol helps SARS-CoV-2 enter cells

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

Early interferon therapy may mitigate COVID-19 severity

New therapy for flu may prove effective against many other pathogenic virus infections

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Hepatitis C News and Research

Latest Hepatitis C News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in